Milena Kamenova Pavlova, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 13 | 2023 | 3290 | 2.020 |
Why?
|
Seizures | 12 | 2023 | 2956 | 1.760 |
Why?
|
REM Sleep Behavior Disorder | 9 | 2023 | 108 | 1.400 |
Why?
|
Circadian Rhythm | 9 | 2024 | 2574 | 1.270 |
Why?
|
Chronobiology Disorders | 3 | 2022 | 73 | 1.180 |
Why?
|
Polysomnography | 12 | 2023 | 1847 | 1.030 |
Why?
|
Brain Waves | 3 | 2014 | 408 | 1.010 |
Why?
|
Melatonin | 7 | 2024 | 669 | 0.900 |
Why?
|
Electroencephalography | 18 | 2023 | 6224 | 0.890 |
Why?
|
Epilepsy, Generalized | 2 | 2020 | 178 | 0.870 |
Why?
|
Sleep | 16 | 2024 | 4765 | 0.810 |
Why?
|
Tachycardia | 2 | 2014 | 600 | 0.760 |
Why?
|
Status Epilepticus | 2 | 2023 | 460 | 0.670 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2023 | 1871 | 0.660 |
Why?
|
Sleep, REM | 3 | 2023 | 594 | 0.650 |
Why?
|
Epilepsies, Partial | 2 | 2020 | 431 | 0.630 |
Why?
|
Continuous Positive Airway Pressure | 4 | 2023 | 575 | 0.550 |
Why?
|
Somatoform Disorders | 1 | 2019 | 423 | 0.510 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2017 | 196 | 0.480 |
Why?
|
Psychophysiologic Disorders | 2 | 2018 | 221 | 0.460 |
Why?
|
Parasomnias | 3 | 2023 | 27 | 0.420 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 88 | 0.410 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.400 |
Why?
|
Conversion Disorder | 1 | 2014 | 202 | 0.380 |
Why?
|
Executive Function | 1 | 2019 | 1389 | 0.350 |
Why?
|
Attention | 2 | 2019 | 2395 | 0.320 |
Why?
|
Death, Sudden | 3 | 2017 | 302 | 0.310 |
Why?
|
Patient Compliance | 1 | 2018 | 2690 | 0.300 |
Why?
|
Wakefulness | 5 | 2017 | 1265 | 0.270 |
Why?
|
Actigraphy | 2 | 2020 | 520 | 0.270 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1780 | 0.260 |
Why?
|
Canada | 2 | 2021 | 2120 | 0.260 |
Why?
|
Plethysmography | 3 | 2014 | 175 | 0.250 |
Why?
|
Nocturnal Myoclonus Syndrome | 2 | 2019 | 51 | 0.250 |
Why?
|
Financing, Personal | 2 | 2011 | 309 | 0.240 |
Why?
|
Sleep Stages | 3 | 2020 | 693 | 0.220 |
Why?
|
Sleep Apnea Syndromes | 2 | 2018 | 975 | 0.210 |
Why?
|
Humans | 54 | 2024 | 761326 | 0.210 |
Why?
|
Arctic Regions | 1 | 2021 | 26 | 0.200 |
Why?
|
Somnambulism | 1 | 2021 | 13 | 0.190 |
Why?
|
Adult | 26 | 2024 | 221122 | 0.190 |
Why?
|
Monitoring, Ambulatory | 2 | 2017 | 354 | 0.190 |
Why?
|
Anticonvulsants | 2 | 2021 | 1906 | 0.190 |
Why?
|
Fees and Charges | 1 | 2002 | 192 | 0.180 |
Why?
|
Middle Aged | 26 | 2024 | 220774 | 0.180 |
Why?
|
Arousal | 2 | 2008 | 1166 | 0.180 |
Why?
|
Brain | 6 | 2021 | 27103 | 0.170 |
Why?
|
Parkinson Disease | 3 | 2021 | 2876 | 0.170 |
Why?
|
Saliva | 1 | 2024 | 827 | 0.170 |
Why?
|
Narcolepsy | 2 | 2018 | 199 | 0.160 |
Why?
|
Wrist | 1 | 2020 | 227 | 0.160 |
Why?
|
Self-Assessment | 1 | 2001 | 396 | 0.160 |
Why?
|
Movement | 2 | 2022 | 1478 | 0.160 |
Why?
|
Male | 33 | 2024 | 360621 | 0.160 |
Why?
|
Mental Recall | 3 | 2023 | 1214 | 0.160 |
Why?
|
National Health Programs | 1 | 2002 | 440 | 0.150 |
Why?
|
Public Opinion | 1 | 2002 | 484 | 0.150 |
Why?
|
Female | 32 | 2024 | 392485 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2947 | 0.150 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 2853 | 0.140 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2018 | 1081 | 0.140 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.140 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 957 | 0.130 |
Why?
|
Aged | 17 | 2024 | 169179 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1086 | 0.120 |
Why?
|
Benzhydryl Compounds | 2 | 2012 | 916 | 0.120 |
Why?
|
Young Adult | 13 | 2019 | 59196 | 0.110 |
Why?
|
Oximetry | 2 | 2014 | 460 | 0.110 |
Why?
|
Stroke | 3 | 2024 | 9749 | 0.110 |
Why?
|
Uric Acid | 1 | 2019 | 808 | 0.110 |
Why?
|
Pilot Projects | 3 | 2019 | 8632 | 0.110 |
Why?
|
Prospective Studies | 8 | 2024 | 54405 | 0.110 |
Why?
|
Attitude to Health | 1 | 2002 | 2025 | 0.100 |
Why?
|
Reaction Time | 1 | 2019 | 2080 | 0.100 |
Why?
|
Time | 2 | 2023 | 545 | 0.100 |
Why?
|
Light | 1 | 2017 | 1351 | 0.090 |
Why?
|
Phototherapy | 2 | 2018 | 368 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2021 | 80575 | 0.090 |
Why?
|
China | 3 | 2024 | 2348 | 0.080 |
Why?
|
Incidence | 3 | 2024 | 21336 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15835 | 0.080 |
Why?
|
Recurrence | 1 | 2021 | 8470 | 0.080 |
Why?
|
Quality of Life | 3 | 2020 | 13355 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 7045 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2667 | 0.080 |
Why?
|
Prevalence | 3 | 2020 | 15719 | 0.080 |
Why?
|
Central Nervous System Depressants | 1 | 2018 | 164 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58946 | 0.070 |
Why?
|
Cognition | 2 | 2022 | 6987 | 0.070 |
Why?
|
Office Visits | 1 | 2011 | 595 | 0.070 |
Why?
|
Adolescent | 9 | 2019 | 88305 | 0.070 |
Why?
|
Restless Legs Syndrome | 1 | 2018 | 233 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9333 | 0.060 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2018 | 277 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2686 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8223 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10498 | 0.060 |
Why?
|
Central Nervous System Stimulants | 2 | 2018 | 1176 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2010 | 843 | 0.050 |
Why?
|
New Zealand | 1 | 2023 | 357 | 0.050 |
Why?
|
Bulgaria | 1 | 2002 | 17 | 0.050 |
Why?
|
Risk Factors | 5 | 2024 | 74152 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18401 | 0.040 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2004 | 389 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2023 | 639 | 0.040 |
Why?
|
Demography | 1 | 2004 | 1648 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6839 | 0.040 |
Why?
|
Video Recording | 1 | 2004 | 966 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 41440 | 0.040 |
Why?
|
Scalp | 1 | 2020 | 389 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1519 | 0.040 |
Why?
|
Random Allocation | 1 | 2001 | 2389 | 0.030 |
Why?
|
Family Characteristics | 1 | 2002 | 1003 | 0.030 |
Why?
|
Lewy Body Disease | 1 | 2019 | 252 | 0.030 |
Why?
|
Parkinsonian Disorders | 1 | 2019 | 284 | 0.030 |
Why?
|
Insulin | 1 | 2010 | 6595 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39108 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1243 | 0.030 |
Why?
|
Health Status | 1 | 2008 | 4075 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1703 | 0.030 |
Why?
|
Child | 2 | 2013 | 80156 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2002 | 2696 | 0.030 |
Why?
|
Health Services Research | 1 | 2002 | 1811 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1740 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 64645 | 0.030 |
Why?
|
Memory | 1 | 2023 | 2187 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12450 | 0.030 |
Why?
|
Clonazepam | 1 | 2013 | 135 | 0.030 |
Why?
|
GABA Modulators | 1 | 2013 | 109 | 0.030 |
Why?
|
Mass Screening | 1 | 2018 | 5428 | 0.030 |
Why?
|
Child, Preschool | 2 | 2013 | 42251 | 0.030 |
Why?
|
Hungary | 1 | 2011 | 83 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22124 | 0.020 |
Why?
|
United States | 1 | 2020 | 72317 | 0.020 |
Why?
|
Apnea | 1 | 2013 | 195 | 0.020 |
Why?
|
Bradycardia | 1 | 2013 | 299 | 0.020 |
Why?
|
Depression | 1 | 2010 | 8122 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 174 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36202 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2010 | 263 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1551 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 29858 | 0.020 |
Why?
|
Basal Metabolism | 1 | 2010 | 161 | 0.020 |
Why?
|
Time Factors | 2 | 2024 | 39974 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8704 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6473 | 0.020 |
Why?
|
Cost Sharing | 1 | 2011 | 409 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 1995 | 1178 | 0.020 |
Why?
|
Hyperinsulinism | 1 | 2010 | 400 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1178 | 0.020 |
Why?
|
Personality Inventory | 1 | 2010 | 1019 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2002 | 4330 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2656 | 0.020 |
Why?
|
Caffeine | 1 | 2010 | 700 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9605 | 0.020 |
Why?
|
Universities | 1 | 2010 | 994 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3122 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3048 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23981 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4921 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10203 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20092 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13500 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14665 | 0.010 |
Why?
|
Heart Rate | 1 | 2013 | 4197 | 0.010 |
Why?
|
Brain Mapping | 1 | 2016 | 6626 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14025 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4405 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26108 | 0.010 |
Why?
|
Students | 1 | 2010 | 1741 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6382 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 6019 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13251 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29588 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4244 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2010 | 2897 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7999 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2010 | 12329 | 0.010 |
Why?
|
Databases, Factual | 1 | 2011 | 7954 | 0.010 |
Why?
|
Blood Glucose | 1 | 2010 | 6389 | 0.010 |
Why?
|
Lung | 1 | 2013 | 9994 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5439 | 0.010 |
Why?
|